Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
IL-17A and multiple sclerosis: signaling pathways, producing cells and target cells in the central nervous system.
Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis.
A Bayesian hierarchical surrogate outcome model for multiple sclerosis.
Physical and social environment and the risk of multiple sclerosis.
What is the true clinicopathologic spectrum of neuromyelitis optica?-Reply.
Stress-stimulated volitional coping competencies and depression in multiple sclerosis.
Ambulation and multiple sclerosis.
Acute disseminated encephalomyelitis.
Biased Homozygous Haplotypes Across the Human Caveolin 1 Upstream Purine Complex in Parkinson's Disease.
A qualitative review of the neurophysiological underpinnings of fatigue in multiple sclerosis.
Sulfocerebrosides upregulate liposome uptake in human astrocytes without inducing a proinflammatory response.
Novel Therapeutic Approach by Nicotine in Experimental Model of Multiple Sclerosis.
Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays.
Duloxetine for the Treatment of Overactive Bladder Syndrome in Multiple Sclerosis: A Pilot Study.
Visual outcome following optic neuritis: A 5-year review.
S-Allylmercapto-N-acetylcysteine (ASSNAC) protects cultured nerve cells from oxidative stress and attenuates experimental autoimmune encephalomyelitis.
Use of the 2010 McDonald Criteria Can Facilitate Early Diagnosis of Pediatric Multiple Sclerosis in a Predominantly Black Cohort.
Preliminary evaluation of variable compliance joystick for people with multiple sclerosis.
A JOINT FRAMEWORK FOR 4D SEGMENTATION AND ESTIMATION OF SMOOTH TEMPORAL APPEARANCE CHANGES.
The relationship of age, function, and psychological distress in multiple sclerosis.
Multiple sclerosis guideline production takes off.
Technical developments of functional electrical stimulation to correct drop foot: Sensing, actuation and control strategies.
Secondary Health Conditions in Individuals With Multiple Sclerosis: A Cross-Sectional Web-Based Survey Analysis.
Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability.
Altered cardiovascular reactivity to mental stress in patients with multiple sclerosis.
Pages
« first
‹ previous
…
382
383
384
385
386
387
388
389
390
…
next ›
last »